JPS60237995A - ストレプトキナ−ゼ産生のための組換えベクタ− - Google Patents

ストレプトキナ−ゼ産生のための組換えベクタ−

Info

Publication number: JPS60237995A
Authority: JP; Japan
Prior art keywords: streptokinase; vector; microorganism; fragment; polydeoxyribonucleotide
Prior art date: 1983-10-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP21240384A

Other languages

English (en)

Japanese (ja)

Inventor

ジヨセフ　ジエイ．フエレツテイ

ホルスト　マルケ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Phillips Petroleum Co

Original Assignee

Phillips Petroleum Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-10-10

Filing date

1984-10-09

Publication date

1985-11-26

1984-10-09 Application filed by Phillips Petroleum Co filed Critical Phillips Petroleum Co

1985-11-26 Publication of JPS60237995A publication Critical patent/JPS60237995A/ja

Status Pending legal-status Critical Current

Links

108010023197 Streptokinase Proteins 0.000 title claims description 81
229960005202 streptokinase Drugs 0.000 title claims description 80
239000013598 vector Substances 0.000 title claims description 64
230000006798 recombination Effects 0.000 title 1
238000005215 recombination Methods 0.000 title 1
239000012634 fragment Substances 0.000 claims description 65
108020004414 DNA Proteins 0.000 claims description 39
244000005700 microbiome Species 0.000 claims description 36
238000000034 method Methods 0.000 claims description 32
241000588724 Escherichia coli Species 0.000 claims description 26
241000194017 Streptococcus Species 0.000 claims description 26
230000002068 genetic effect Effects 0.000 claims description 26
108091008146 restriction endonucleases Proteins 0.000 claims description 25
230000028327 secretion Effects 0.000 claims description 25
230000015572 biosynthetic process Effects 0.000 claims description 22
102220489870 Cofilin-1_H46A_mutation Human genes 0.000 claims description 21
238000003786 synthesis reaction Methods 0.000 claims description 20
239000013612 plasmid Substances 0.000 claims description 11
101710163270 Nuclease Proteins 0.000 claims description 10
241000588722 Escherichia Species 0.000 claims description 7
239000002773 nucleotide Substances 0.000 claims description 7
125000003729 nucleotide group Chemical group 0.000 claims description 7
241000894007 species Species 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 6
239000002609 medium Substances 0.000 claims description 4
235000015097 nutrients Nutrition 0.000 claims description 4
238000003776 cleavage reaction Methods 0.000 claims description 3
239000001963 growth medium Substances 0.000 claims description 3
230000007017 scission Effects 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims description 2
230000001131 transforming effect Effects 0.000 claims description 2
230000000813 microbial effect Effects 0.000 claims 3
239000005547 deoxyribonucleotide Substances 0.000 claims 2
125000002637 deoxyribonucleotide group Chemical group 0.000 claims 2
FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 claims 1
241000951471 Citrus junos Species 0.000 claims 1
108010042407 Endonucleases Proteins 0.000 claims 1
102000004533 Endonucleases Human genes 0.000 claims 1
108091000080 Phosphotransferase Proteins 0.000 claims 1
108020004511 Recombinant DNA Proteins 0.000 claims 1
235000020971 citrus fruits Nutrition 0.000 claims 1
238000012258 culturing Methods 0.000 claims 1
102000020233 phosphotransferase Human genes 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 21
229940023064 escherichia coli Drugs 0.000 description 19
210000004027 cell Anatomy 0.000 description 12
208000007536 Thrombosis Diseases 0.000 description 11
235000018102 proteins Nutrition 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
239000000243 solution Substances 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
230000000694 effects Effects 0.000 description 8
241000701959 Escherichia virus Lambda Species 0.000 description 7
239000000203 mixture Substances 0.000 description 7
239000000047 product Substances 0.000 description 7
230000000963 caseinolytic effect Effects 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
101710145796 Staphylokinase Proteins 0.000 description 4
230000017531 blood circulation Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
230000029087 digestion Effects 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
241001515965 unidentified phage Species 0.000 description 4
241000193830 Bacillus <bacterium> Species 0.000 description 3
208000005189 Embolism Diseases 0.000 description 3
241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 3
208000001435 Thromboembolism Diseases 0.000 description 3
239000013611 chromosomal DNA Substances 0.000 description 3
210000000805 cytoplasm Anatomy 0.000 description 3
230000002949 hemolytic effect Effects 0.000 description 3
101150086266 skc gene Proteins 0.000 description 3
229920000936 Agarose Polymers 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
239000006142 Luria-Bertani Agar Substances 0.000 description 2
JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
244000292604 Salvia columbariae Species 0.000 description 2
235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 2
235000001498 Salvia hispanica Nutrition 0.000 description 2
239000007994 TES buffer Substances 0.000 description 2
206010000891 acute myocardial infarction Diseases 0.000 description 2
210000002565 arteriole Anatomy 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
239000005018 casein Substances 0.000 description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
235000021240 caseins Nutrition 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
235000014167 chia Nutrition 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000009826 distribution Methods 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
230000020764 fibrinolysis Effects 0.000 description 2
DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 2
239000010410 layer Substances 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
239000006166 lysate Substances 0.000 description 2
239000008188 pellet Substances 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
239000000523 sample Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000032258 transport Effects 0.000 description 2
229920001817 Agar Polymers 0.000 description 1
101100234244 Arabidopsis thaliana KDTA gene Proteins 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
241000510930 Brachyspira pilosicoli Species 0.000 description 1
241001478240 Coccus Species 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
230000007023 DNA restriction-modification system Effects 0.000 description 1
101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 1
241000702192 Escherichia virus P2 Species 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
101100190845 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pmp-1 gene Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101001116283 Phanerodontia chrysosporium Manganese peroxidase H4 Proteins 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
101001018261 Protopolybia exigua Mastoparan-1 Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
238000002298 density-gradient ultracentrifugation Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
230000010435 extracellular transport Effects 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
239000003527 fibrinolytic agent Substances 0.000 description 1
230000003480 fibrinolytic effect Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
239000013038 irreversible inhibitor Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000008155 medical solution Substances 0.000 description 1
239000011259 mixed solution Substances 0.000 description 1
108010009719 mutanolysin Proteins 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
239000011734 sodium Substances 0.000 description 1
-1 sodium decyl sulfate-potassium sulfate Chemical compound 0.000 description 1
BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
229910001488 sodium perchlorate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
229960000103 thrombolytic agent Drugs 0.000 description 1
230000001732 thrombotic effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Landscapes

Enzymes And Modification Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

JP21240384A 1983-10-10 1984-10-09 ストレプトキナ−ゼ産生のための組換えベクタ− Pending JPS60237995A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DD12N/2555235		1983-10-10
DD25552383A DD249037A1 (de)	1983-10-10	1983-10-10	Verfahren zur synthese von streptokinase durch heterologe produzenten
US585417		1984-03-02

Publications (1)

Publication Number	Publication Date
JPS60237995A true JPS60237995A (ja)	1985-11-26

Family

ID=5550980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP21240384A Pending JPS60237995A (ja)	1983-10-10	1984-10-09	ストレプトキナ−ゼ産生のための組換えベクタ−

Country Status (4)

Country	Link
JP (1)	JPS60237995A (de)
DD (1)	DD249037A1 (de)
GR (1)	GR80577B (de)
ZA (1)	ZA847873B (de)

1983
- 1983-10-10 DD DD25552383A patent/DD249037A1/de not_active IP Right Cessation
1984
- 1984-10-08 GR GR80577A patent/GR80577B/el unknown
- 1984-10-08 ZA ZA847873A patent/ZA847873B/xx unknown
- 1984-10-09 JP JP21240384A patent/JPS60237995A/ja active Pending

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOCHEMISTRY=1982 *

Also Published As

Publication number	Publication date
DD249037A1 (de)	1987-08-26
ZA847873B (en)	1985-05-29
GR80577B (en)	1985-02-12

Publication	Publication Date	Title
Chmouryguina et al.	1996	Conservation of the C5a peptidase genes in group A and B streptococci
JP3581352B2 (ja)	2004-10-27	ウレアーゼの調節及び成熟のために必要なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉの遺伝子及びその用途
JPH08196283A (ja)	1996-08-06	ウレアーゼ活性を有するタンパク質をコードするヌクレオチド配列
Nyberg et al.	2004	Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes
EP1032675B1 (de)	2010-08-04	Befestigung von substanzen an mikroorganismen
Johnsen et al.	1999	Purification and cloning of a streptokinase from Streptococcus uberis
Jimenez-Lucho et al.	1986	Failure of therapy in Pseudomonas endocarditis: selection of resistant mutants
Andreoli et al.	1978	Genetic map of the bacteriocinogenic plasmid Clo DF13 derived by insertion of the transposon Tn 901
Piras et al.	1990	Characterization of an Enterococcus hirae penicillin-binding protein 3 with low penicillin affinity
Park et al.	1993	Characterization of the tpr gene product and isolation of a specific protease-deficient mutant of Porphyromonas gingivalis W83
Bolyard et al.	1988	High-level expression of a functional human fibrinogen gamma chain in Escherichia coli
US5290916A (en)	1994-03-01	Purified glucanase enzymes
CA2101781A1 (en)	1992-07-16	Pasteurella haemolytica glycoprotease gene and the purified enzyme
JPH05320197A (ja)	1993-12-03	スタヒロコッカス・アウレウス菌株２７ｒ由来のペニシリン結合タンパク質２ａのｄｎａおよびアミノ酸配列およびその精製に用いるための誘導体およびメシチリン耐性生物に対して有効な化合物の検定法
EP0151337B1 (de)	1991-03-20	Streptokinase kodierende rekombinante Vektoren
JPS60237995A (ja)	1985-11-26	ストレプトキナ−ゼ産生のための組換えベクタ−
US4764469A (en)	1988-08-16	Streptokinase-coding recombinant vectors
US5066589A (en)	1991-11-19	Streptokinase-coding recombinant vectors
Sarvas et al.	1983	The penicillinase of Bacillus licheniformis is an outer membrane protein in Escherichia coli
RU2127758C1 (ru)	1999-03-20	Способ получения рекомбинантной стрептокиназы
Wellisch et al.	1984	Simple method for collagenase determination in 38 Pseudomonas aeruginosa strains
JPS62296881A (ja)	1987-12-24	酵母ｄｎａフラグメント及びその利用
CN119080950A (zh)	2024-12-06	一种宽体金线蛭失稳酶融合蛋白及其应用
Rehemtulla	1988	Isolation, characterization and regulation of expression of plasminogen activator inhibitors from tissue culture cells
Mani	1995	Molecular analyses of the autolytic system of Staphylococcus aureus